Prognostic impact of peripheral blood Wilms’ tumour 1 mRNA expression levels in response to azacytidine in MDS: A single-centre analysis

To determine the impact of peripheral blood (PB) Wilms’ tumour 1 (WT-1) mRNA levels in patients with primary myelodysplastic syndromes (MDS), we analysed the relationships between several clinical variables at the time of diagnosis and the haematological response of patients treated with azacytidine...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Tomoya, Matsuda, Akira, Asou, Chie, Okamura, Daisuke, Tanae, Ken, Kohri, Mika, Ishikawa, Maho, Takahashi, Naoki, Tsukasaki, Kunihiro, Kawai, Nobutaka, Asou, Norio, Bessho, Masami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744716/
https://www.ncbi.nlm.nih.gov/pubmed/33354513
http://dx.doi.org/10.1016/j.lrr.2020.100231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7744716/
https://www.ncbi.nlm.nih.gov/pubmed/33354513
http://dx.doi.org/10.1016/j.lrr.2020.100231

Ejemplares similares